{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:45:43Z","timestamp":1792478743517,"version":"4.5.0"},"reference-count":29,"publisher":"Academy of Medicine, Singapore","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Acad Med Singap"],"published-print":{"date-parts":[[2022,1,25]]},"abstract":"<jats:p>ABSTRACT\nIntroduction: Nail psoriasis treatment is challenging due to difficult drug delivery and systemic therapy\ntoxicities. Self-dissolvable microneedle patches embedded with corticosteroids offers a potentially rapid,\nminimally invasive drug delivery platform with good efficacy and minimal adverse side effects.\nMethods: We conducted a 4-month prospective randomised controlled trial. Subjects with psoriatic\nnails were randomised to receive microneedle device delivered topical steroids on one hand and control\ntreatment (topical Daivobet gel) on the other. Two independent dermatologists blinded to the treatment\nassignment scored their Nail Psoriasis Severity Index (NAPSI) during visits at baseline, 2 and 4 months.\nAll treatment was discontinued after 2 months. Average NAPSI score on each hand was analysed.\nResults: A total of 25 participants were recruited, aged 22 to 73 years. Majority were Chinese\n(72%), followed by Indian and Malay. There was equal randomisation of treatment to the left and right\nnail. While there was a rapid significant improvement in average NAPSI score for the control arm at 2\nmonths, the treatment arm had a greater, more sustained improvement of the NAPSI score at 4 months.\nThe average NAPSI score improved for both treatment and control group at 4 months compared to\nbaseline. However, only the NAPSI value improvement in the controls at 2 months compared to baseline\nwas statistically significant (P=0.0039). No severe adverse effects were reported.\nConclusion: To the best of our knowledge, this is the first prospective randomised control trial\ncomparing microneedle technology against conventional topical steroids in nail psoriasis treatment. Our\nfindings demonstrate microneedle technology is as efficacious as topical therapy.\n\nKeywords: Microneedle, nail, psoriasis<\/jats:p>","DOI":"10.47102\/annals-acadmedsg.2021380","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T11:18:04Z","timestamp":1643109484000},"page":"16-23","source":"Crossref","is-referenced-by-count":20,"title":["Novel transdermal device for delivery of triamcinolone for\nnail psoriasis treatment"],"prefix":"10.47102","volume":"51","author":[{"given":"Yik Weng","family":"Yew","sequence":"first","affiliation":[{"name":"National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal Zhen Yu","family":"Phuan","sequence":"additional","affiliation":[{"name":"National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiahong","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Sern Ting","family":"Tan","sequence":"additional","affiliation":[{"name":"National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Chong","sequence":"additional","affiliation":[{"name":"National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Liang","family":"Tey","sequence":"additional","affiliation":[{"name":"National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"26165","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004 (Erratum in J Am Acad Dermatol 2009;61:507). J Am Acad Dermatol 2009;60:218-24.","DOI":"10.1016\/j.jaad.2008.09.022"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.","DOI":"10.1001\/archderm.141.12.1537"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl 2):ii14-7.","DOI":"10.1136\/ard.2004.032482"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Jiaravuthisan MM, Sasseville D, Vender RB, et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007;57:1-27.","DOI":"10.1016\/j.jaad.2005.07.073"},{"key":"ref4","unstructured":"Tham SN, Lim JJ, Tay SH, et al. Clinical observations on nail changes in psoriasis. Ann Acad Med Singap 1988;17482-5."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: a prospective clinical study. J Cutan Med Surg 2003;7:317-21.","DOI":"10.1007\/s10227-002-0143-0"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Klaassen KM, van de Kerkhof PC, Pasch MC. Nail psoriasis: a questionnaire-based survey. Br J Dermatol 2013;169:314-9.","DOI":"10.1111\/bjd.12354"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Langenbruch A, Radtke MA, Krensel M, et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol 2014;171:1123-8.","DOI":"10.1111\/bjd.13272"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"de Jong EM, Seegers BA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996;193:300-3.","DOI":"10.1159\/000246274"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Klaassen KM, van de Kerkhof PC, Pasch MC. Nail Psoriasis, the unknown burden of disease. J Eur Acad Dermatol Venereol 2014;28:1690-5.","DOI":"10.1111\/jdv.12368"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"de Berker D. Management of nail psoriasis. Clin Exp Dermatol 2000;25:357-62.","DOI":"10.1046\/j.1365-2230.2000.00663.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Oram Y, Karincao\u011flu Y, Koyuncu E, et al. Pulsed dye laser in the treatment of nail psoriasis. Dermatol Surg 2010;36:377-81.","DOI":"10.1111\/j.1524-4725.2009.01448.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Reich K. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 2009;23(Suppl 1):15-21.","DOI":"10.1111\/j.1468-3083.2009.03364.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Armstrong AW, Tuong W, Love TJ, et al. Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group. J Rheumatol 2014;41:2306-14.","DOI":"10.3899\/jrheum.140881"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Zhu Z, Luo H, Lu W, et al. Rapidly dissolvable microneedle patches for transdermal delivery of exenatide. Pharm Res 2014; 31:3348-60.","DOI":"10.1007\/s11095-014-1424-1"},{"key":"ref15","unstructured":"Cassell S, Kavanaugh AF. Therapies for psoriatic nail disease. A systematic review. J Rheumatol 2006;33:1452-6."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003;49:206-12.","DOI":"10.1067\/s0190-9622(03)00910-1"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Igarashi A, Kato T, Kato M, et al. Japanese Ustekinumab Study Group. Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2\/3 clinical trial. J Dermatol 2012;39:242-52.","DOI":"10.1111\/j.1346-8138.2011.01347.x"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Rich P, Bourcier M, Sofen H, et al. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1. Br J Dermatol 2014;170:398-407.","DOI":"10.1111\/bjd.12632"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Marwah H, Garg T, Goyal AK, et al. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 2016;23:564-78.","DOI":"10.3109\/10717544.2014.935532"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Zhao Z, Chen Y, Shi Y. Microneedles: a potential strategy in transdermal delivery and application in the management of psoriasis. RSC Advances 2020;10:14040-9.","DOI":"10.1039\/D0RA00735H"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Nguyen HX, Banga AK. Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser. Pharm Res 2018;35:68.","DOI":"10.1007\/s11095-018-2369-6"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Du H, Liu P, Zhu J, et al. Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis. ACS Appl Mater Interfaces 2019;11:43588-98.","DOI":"10.1021\/acsami.9b15668.s001"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"So JW, Park HH, Lee SS, et al. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations. Drug Deliv 2009;16:52-6.","DOI":"10.1080\/10717540802518082"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Jeong HR, Kim JY, Kim SN, et al. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles. Eur J Pharm Biopharm 2018;127:237-43.","DOI":"10.1016\/j.ejpb.2018.02.014"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Korkmaz E, Friedrich EE, Ramadan MH, et al. Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays. Acta Biomater 2015;24:96-105.","DOI":"10.1016\/j.actbio.2015.05.036"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Korkmaz E, Friedrich EE, Ramadan MH, et al. Tip-Loaded Dissolvable Microneedle Arrays Effectively Deliver Polymer- Conjugated Antibody Inhibitors of Tumor-Necrosis-Factor-Alpha Into Human Skin. J Pharm Sci 2016;105:3453-7.","DOI":"10.1016\/j.xphs.2016.07.008"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Lee JH, Jung YS, Kim GM, et al. A hyaluronic acid-based microneedle patch to treat psoriatic plaques: a pilot open trial. Br J Dermatol 2018;178:e24-5.","DOI":"10.1111\/bjd.15779"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Cary JH, Li BS, Maibach HI. Dermatotoxicology of microneedles (MNs) in man. Biomed Microdevices 2019;21:66.","DOI":"10.1007\/s10544-019-0371-3"}],"container-title":["Annals of the Academy of Medicine, Singapore"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T11:18:14Z","timestamp":1643109494000},"score":1,"resource":{"primary":{"URL":"https:\/\/annals.edu.sg\/novel-transdermal-device-for-delivery-of-triamcinolone-for-nail-psoriasis-treatment\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,25]]},"published-print":{"date-parts":[[2022,1,25]]}},"URL":"https:\/\/doi.org\/10.47102\/annals-acadmedsg.2021380","relation":{},"ISSN":["0304-4602"],"issn-type":[{"value":"0304-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}